Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Emily Peterson Insider Profile
4 Followers
Emily Peterson, Director at Amneal Pharmaceuticals, holds 27.30K shares in Alkermes (Ticker: ALKS), holds 250.77K shares in Amneal Pharmaceuticals (Ticker: AMRX).
Emily Peterson has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Emily Peterson holds in companies
Most Profitable Insider Trade
The most profitable trade made by Emily Peterson
Emily Peterson's Trading History
Amneal Pharmaceuticals
May 14, 2024
Director
Uninformative Buy
509.18K
$2.11M
Alkermes
Jul 01, 2024
Director
Uninformative Buy
111.80K
$762.00K
List of latest transactions for each holding click on a transaction to see Emily Peterson's performance on stock
You May Also Like
Emily Peterson insider profile FAQ
What is the percentage of profitable transactions made by Emily Peterson?
The percentage of profitable transactions made by Emily Peterson is ―.
What is the average return per transaction made by Emily Peterson?
The average return per transaction made by Emily Peterson is ―.
What stocks does Emily Peterson hold?
Emily Peterson holds: AMRX, ALKS stocks.
What was Emily Peterson’s latest transaction?
Emily Peterson latest transaction was an Uninformative Buy of $111.80K.
What was Emily Peterson's most profitable transaction?
Emily Peterson’s most profitable transaction was an Informative Buy of ALKS stock on August 24, 2021. The return on the trade was -16.90%.
What is Emily Peterson's role in Amneal Pharmaceuticals?
Emily Peterson's role in Amneal Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.